TY  - GEN
AU  - Hellmann,M D
AU  - Kim,T-W
AU  - Lee,C B
AU  - Goh,B-C
AU  - Miller,W H
AU  - Oh,D-Y
AU  - Jamal,R
AU  - Chee,C-E
AU  - Chow,L Q M
AU  - Gainor,J F
AU  - Desai,J
AU  - Solomon,B J
AU  - Das Thakur,M
AU  - Pitcher,B
AU  - Foster,P
AU  - Hernandez,G
AU  - Wongchenko,M J
AU  - Cha,E
AU  - Bang,Y-J
AU  - Siu,L L
AU  - Bendell,J
TI  - Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors
SN  - 1569-8041
PY  - 2020///0623
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacokinetics
KW  - Azetidines
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Piperidines
KW  - Prognosis
KW  - Survival Rate
KW  - Tissue Distribution
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdz113
ER  -